News

Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...
Kurdi, Amanj, Tanja Mueller, and Natalie Weir. 2022. “An Umbrella Review and Meta‐Analysis of Renin–Angiotensin System Drugs Use and COVID ‐19 Outcomes.” ...
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting–enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.